share_log
Reuters ·  05/03 16:08

Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29

Brainstorm Cell Therapeutics:收到納斯達克的來信,表明截至4月29日,該公司尚未恢復遵守最低出價要求

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論